Product Images Tamsulosin Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Tamsulosin Hydrochloride NDC 63187-358 by Proficient Rx Lp, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-Dose Administration of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted and Fed Conditions (n=8) - tamsulosin fig1

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1 - tamsulosin fig2

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2 - tamsulosin fig3

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

Figure 3A Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1 - tamsulosin fig4

Figure 3A shows the results of a study, displaying the mean increase in peak urine flow rate measured in L/sec. Three treatment groups were given different doses of medication or a placebo. The study lasted for a variable duration of weeks, with a total of 635, 621, 617, 755, 752, 713, and 694 participants in each respective treatment group.*

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

Figure 3B Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2 - tamsulosin fig5

The text describes a figure labeled "Figure 3B" which shows the mean increase in peak urine flow rate measured in mL/Sec for a study labeled "Study 2". The figure includes a graph with the x-axis labeled "Duration of Treatment (weeks)" and the y-axis labeled "Mean Increase in Peak Urine Flow Rate (mL/Sec)". The graph shows a line increasing for 20 weeks of treatment. However, there is some unreadable text in the figure that is not available for evaluation.*

63187-358-30 - tamsulosin fig6

63187-358-30 - tamsulosin fig6

This is a description of Tamsulosin HCI 0.4mg, a medication packaged by Proficient Rx LP in Thousand Oaks, CA. The package contains 30 olive green/orange opaque hard gelatin capsules imprinted with L A0 on the cap, and 53 on the body, each filled with white to off-white beadets. Every capsule contains Tamsulosin Hydrochloride USP 0.4mg, and the product has a lot number of 00000 and an expiration date of 00/00/00. The medication is distributed by Rising Health, LLC, Saddle Brook, NJ, and manufactured in India. It should be stored at 20°-25°C (68°77°F) and kept out of the reach of children.*

Chemical Structure - tamsulosin str

Chemical Structure - tamsulosin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.